{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:50:48Z","timestamp":1781851848142,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T00:00:00Z","timestamp":1668988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100018525","name":"Key Research and Development Project of Sichuan Province","doi-asserted-by":"crossref","award":["2020YFS0273"],"award-info":[{"award-number":["2020YFS0273"]}],"id":[{"id":"10.13039\/501100018525","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Project of Sichuan Health Commission","award":["20PJ008"],"award-info":[{"award-number":["20PJ008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s00432-022-04481-5","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T23:04:40Z","timestamp":1669158280000},"page":"2693-2698","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Progress in the treatment of urethral adenocarcinoma"],"prefix":"10.1007","volume":"149","author":[{"given":"Jiamin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,21]]},"reference":[{"issue":"5","key":"4481_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1046\/j.1442-2042.2003.00613.x","volume":"10","author":"Y Awakura","year":"2003","unstructured":"Awakura Y et al (2003) Adenocarcinoma of the female urethral diverticulum treated by multimodality therapy. Int J Urol 10(5):281\u2013283","journal-title":"Int J Urol"},{"issue":"4","key":"4481_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.kjms.2010.12.009","volume":"27","author":"LP Chen","year":"2011","unstructured":"Chen LP et al (2011) Locally advanced female urethral adenocarcinoma of enteric origin: the role of adjuvant chemoradiation and brief review. Kaohsiung J Med Sci 27(4):150\u2013154","journal-title":"Kaohsiung J Med Sci"},{"issue":"3","key":"4481_CR3","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1006\/gyno.2000.5968","volume":"279","author":"YM Chan","year":"2000","unstructured":"Chan YM et al (2000) Female urethral adenocarcinoma arising from urethritis glandularis. Gynecol Oncol 279(3):511\u2013514","journal-title":"Gynecol Oncol"},{"issue":"3","key":"4481_CR4","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.canrad.2015.11.005","volume":"20","author":"M Deberne","year":"2016","unstructured":"Deberne M et al (2016) Multimodal management of primary adenocarcinoma of the female urethra: about four cases. Cancer Radiother 20(3):169\u2013175","journal-title":"Cancer Radiother"},{"issue":"1","key":"4481_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00345-012-0882-5","volume":"31","author":"JW Derksen","year":"2013","unstructured":"Derksen JW et al (2013) Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival. World J Urol 31(1):147\u2013153","journal-title":"World J Urol"},{"issue":"5","key":"4481_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S1078-1439(03)00174-1","volume":"22","author":"DS Dimarco","year":"2004","unstructured":"Dimarco DS et al (2004) Surgical treatment for local control of female urethral carcinoma. Urol Oncol 22(5):404\u2013409","journal-title":"Urol Oncol"},{"issue":"6","key":"4481_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1046\/j.1464-410X.1998.00878.x","volume":"82","author":"G Dalbagni","year":"1998","unstructured":"Dalbagni G et al (1998) Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy. Br J Urol 82(6):835\u2013841","journal-title":"Br J Urol"},{"key":"4481_CR8","doi-asserted-by":"crossref","unstructured":"Grivas P et al (2019) Conceptual framework for therapeutic development beyond anti-PD-1\/PD-L1 in urothelial cancer. American society of clinical oncology educational book. American society of clinical oncology. Annu Meet 39:284\u2013300","DOI":"10.1200\/EDBK_237449"},{"issue":"1","key":"4481_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4103\/IJPM.IJPM_745_16","volume":"61","author":"P Gangadhar","year":"2018","unstructured":"Gangadhar P et al (2018) A rare case of primary female urethral adenocarcinoma: columnar type with colonic adenocarcinoma features. Indian J Pathol Microbiol 61(1):127\u2013130","journal-title":"Indian J Pathol Microbiol"},{"key":"4481_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.humpath.2015.09.014","volume":"47","author":"SE Harari","year":"2016","unstructured":"Harari SE et al (2016) Primary mucinous adenocarcinoma of the female urethra: a contemporary clinicopathologic analysis. Hum Pathol 47:132\u2013137","journal-title":"Hum Pathol"},{"issue":"4","key":"4481_CR11","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/iju.12333","volume":"21","author":"J Itoh","year":"2014","unstructured":"Itoh J et al (2014) Docetaxel, cisplatin and 5-fluorouracil chemotherapy with concurrent radiation for unresectable advanced urethral carcinoma. Int J Urol 21(4):422\u2013424","journal-title":"Int J Urol"},{"issue":"10","key":"4481_CR12","doi-asserted-by":"publisher","first-page":"731.e1","DOI":"10.1016\/j.urolonc.2020.12.021","volume":"39","author":"J Jacob","year":"2021","unstructured":"Jacob J et al (2021) Comprehensive genomic profiling of histologic subtypes of urethral carcinomas. Urol Oncol 39(10):731.e1-731.e15","journal-title":"Urol Oncol"},{"issue":"6","key":"4481_CR13","first-page":"790","volume":"98","author":"T Koizumi","year":"2007","unstructured":"Koizumi T et al (2007) Two cases of primary female urethral cancer. Nihon Hinyokika Gakkai Zasshi 98(6):790\u2013794 (Japanese)","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"issue":"4","key":"4481_CR14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1600-0463.2006.apm_345.x","volume":"114","author":"N Kuroda","year":"2006","unstructured":"Kuroda N et al (2006) Female urethral adenocarcinoma with a heterogeneous phenotype. APMIS 114(4):314\u2013318","journal-title":"APMIS"},{"issue":"5","key":"4481_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s10147-005-0497-6","volume":"10","author":"S Kurosaka","year":"2005","unstructured":"Kurosaka S et al (2005) Advanced clear-cell adenocarcinoma of the bladder successfully treated by radical surgery with adjuvant chemoradiotherapy. Int J Clin Oncol 10(5):362\u2013365","journal-title":"Int J Clin Oncol"},{"key":"4481_CR16","doi-asserted-by":"crossref","unstructured":"Lagarde-Lenon MS, Aron M (2022) Female urethral carcinoma: a contemporary review of the clinicopathologic features, with emphasis on the histo-anatomic landmarks and potential staging issues. Hum Pathol 129:71\u201380","DOI":"10.1016\/j.humpath.2022.08.003"},{"issue":"3","key":"4481_CR17","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.4081\/rt.2010.e55","volume":"2","author":"B Libby","year":"2010","unstructured":"Libby B et al (2010) Non-surgical treatment of primary female urethral cancer. Rare Tumors 2(3):e55","journal-title":"Rare Tumors"},{"key":"4481_CR301","doi-asserted-by":"crossref","unstructured":"Ma J et al (2022) Immune checkpoint inhibitor in a case with primary urethral adenocarcinoma with lung metastasis. Anticancer Drugs 33(10):1163\u20131166","DOI":"10.1097\/CAD.0000000000001351"},{"key":"4481_CR18","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.urology.2017.11.033","volume":"113","author":"P Mendiratta","year":"2018","unstructured":"Mendiratta P et al (2018) Organ preservation for recurrent urethral adenocarcinoma with concurrent chemotherapy and radiation. Urology 113:e1\u2013e2","journal-title":"Urology"},{"issue":"3","key":"4481_CR19","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.ajpath.2013.11.023","volume":"184","author":"R Mehra","year":"2014","unstructured":"Mehra R et al (2014) Primary urethral clear-cell adenocarcinoma: comprehensive analysis by surgical pathology, cytopathology, and next-generation sequencing. Am J Pathol 184(3):584\u2013591","journal-title":"Am J Pathol"},{"key":"4481_CR300","doi-asserted-by":"crossref","unstructured":"Mujkanovic J et al (2016) Successful treatment of a 67-year-old woman with urethral adenocarcinoma with the use of external beam radiotherapy and image guided adaptive interstitial brachytherapy. J Contemp Brachytherapy 8(5):434\u2013437","DOI":"10.5114\/jcb.2016.63461"},{"issue":"5","key":"4481_CR20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1177\/1066896920988348","volume":"29","author":"C Padilla-Ansala","year":"2021","unstructured":"Padilla-Ansala C et al (2021) Histopathological subtypes and PD-L1 expression in primary urethral adenocarcinoma: a series of 5 cases. Int J Surg Pathol 29(5):488\u2013495","journal-title":"Int J Surg Pathol"},{"issue":"3","key":"4481_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley RS et al (2019) Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov 18(3):175\u2013196","journal-title":"Nat Rev Drug Discov"},{"key":"4481_CR22","doi-asserted-by":"crossref","unstructured":"Rane SR et al (2017) Clear cell adenocarcinoma of female urethra. J Clin Diagn Res11(7):ED01\u2013ED02","DOI":"10.7860\/JCDR\/2017\/25261.10127"},{"issue":"2","key":"4481_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ijrobp.2018.06.007","volume":"102","author":"CH Son","year":"2018","unstructured":"Son CH et al (2018) Optimizing the role of surgery and radiation therapy in urethral cancer based on histology and disease extent. Int J Radiat Oncol Biol Phys 102(2):304\u2013313","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4481_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.urology.2016.09.042","volume":"100","author":"W Sui","year":"2017","unstructured":"Sui W et al (2017) Outcomes and prognostic factors of primary urethral cancer. Urology 100:180\u2013186","journal-title":"Urology"},{"issue":"1","key":"4481_CR25","first-page":"38","volume":"7","author":"A Satyanarayan","year":"2015","unstructured":"Satyanarayan A et al (2015) Adenocarcinoma of the urethra with mucinous features. Rev Urol 7(1):38\u201341","journal-title":"Rev Urol"},{"issue":"3","key":"4481_CR26","first-page":"549","volume":"104","author":"T Suzuki","year":"2013","unstructured":"Suzuki T et al (2013) Long-term survival of metastatic clear cell adenocarcinoma of the female urethra by multidisciplinary treatment: a case report. Nihon Hinyokika Gakkai Zasshi 104(3):549\u2013553","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"issue":"6","key":"4481_CR27","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.urology.2006.08.1057","volume":"68","author":"MA Swartz","year":"2006","unstructured":"Swartz MA et al (2006) Incidence of primary urethral carcinoma in the United States. Urology 68(6):1164\u20131168","journal-title":"Urology"},{"issue":"1","key":"4481_CR28","first-page":"43","volume":"5","author":"H Tanaka","year":"2009","unstructured":"Tanaka H et al (2009) Primary adenocarcinoma of the female urethra treated by multimodal therapy. Hinyokika Kiyo 5(1):43\u201346","journal-title":"Hinyokika Kiyo"},{"key":"4481_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2021.101654","volume":"37","author":"P Viswambaram","year":"2021","unstructured":"Viswambaram P et al (2021) Adenocarcinoma of the urethra: a rare subtype of urethral cancer. Urol Case Rep 37:101654","journal-title":"Urol Case Rep"},{"issue":"4","key":"4481_CR30","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ejca.2011.10.031","volume":"48","author":"O Visser","year":"2012","unstructured":"Visser O et al (2012) Incidence and survival of rare urogenital cancers in Europe. Eur J Cancer 48(4):456\u2013464","journal-title":"Eur J Cancer"},{"issue":"1","key":"4481_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/CMR.0000000000000521","volume":"29","author":"N Yang","year":"2019","unstructured":"Yang N et al (2019) Primary malignant melanotic melanoma and hypomelanotic melanoma of the female urethra: case series and a review of the literature in China. Melanoma Res 29(1):59\u201364","journal-title":"Melanoma Res"},{"issue":"4","key":"4481_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ucl.2016.06.011","volume":"43","author":"LN Zinman","year":"2016","unstructured":"Zinman LN, Vanni AJ (2016) Management of proximal primary urethral cancer: should multidisciplinary therapy be the gold standard? Urol Clin N Am 43(4):505\u2013513","journal-title":"Urol Clin N Am"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04481-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-022-04481-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-022-04481-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T10:11:10Z","timestamp":1682417470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-022-04481-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,21]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["4481"],"URL":"https:\/\/doi.org\/10.1007\/s00432-022-04481-5","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,21]]},"assertion":[{"value":"16 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}